Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro

URN to cite this document:: urn:nbn:de:bvb:355-epub-355421
DOI to cite this document:: 10.5283/epub.35542

Schüler-Toprak, Susanne ; Häring, Julia ; Inwald, Elisabeth C. ; Moehle, Christoph ; Ortmann, Olaf ; Treeck, Oliver

Preview

License: Creative Commons Attribution 4.0
PDF
(985kB)

Date of publication of this fulltext: 19 Apr 2017 11:03

Alternative links to fulltext:DOI Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

Background: Estrogen receptor beta (ER beta) is expressed in the majority of invasive breast cancer cases, irrespective of their subtype, including triple-negative breast cancer (TNBC). Thus, ER beta might be a potential target for therapy of this challenging cancer type. In this in vitro study, we examined the role of ER beta in invasion of two triple-negative breast cancer cell lines. Methods: ...